A Platform for Comprehensive CRISPR/Cas9 Genome Editing in Preclinical Research and Drug Discovery

About this poster

This poster illustrates the capabilities of IRBM’s CRISPR/Cas9 genome editing platform, designed to generate tailored cellular models for translational research. Applications span from gene knock-outs to targeted insertions and point mutations, across both immortalized and stem cell systems. The platform supports target validation, mechanistic studies, and therapeutic evaluation in areas including neurodegeneration, oncology, and rare diseases.